Financials
Income statement
| Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 11.2B | 9.8B | 12.7B | 10.3B |
| Cost of revenue | 8.8B | 7.6B | 9.5B | 7.6B |
| Gross profit | 2.4B | 2.2B | 3.1B | 2.7B |
| Operating expense | ||||
| Research & development | 266.3M | 252.2M | 216.2M | 314.7M |
| Selling general and admin | 142.7M | 167.0M | 152.4M | 255.3M |
| Other operating expenses | 30.0M | 25.8M | 27.6M | 38.3M |
| Operating income | 1.2B | 968.5M | 1.9B | 1.3B |
| Non operating interest income | ||||
| Income | 255.2M | 217.2M | 186.1M | 182.5M |
| Expense | 6.6M | 7.3M | 40.3M | 41.0M |
| Other income expense | — | — | — | — |
| Pretax income | 1.4B | 1.3B | 2.1B | 1.5B |
| Tax provision | 114.6M | 142.1M | 300.2M | 283.3M |
| Net income | 1.3B | 1.2B | 1.8B | 1.2B |
| Basic EPS | — | 127 | 192 | 133 |
| Diluted EPS | — | 127 | 191 | 132 |
| Basic average shares | — | 9.3M | 9.3M | — |
| Diluted average shares | — | 9.3M | 9.3M | — |
| EBITDA | 1.7B | 1.6B | 2.4B | 1.7B |
| Net income from continuing op. | 1.3B | 1.2B | 1.8B | 1.2B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |